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The relationship between hospital and ehr
vendor market dynamics on health
information organization presence and
participation
Sunny C. Lin1* and Julia Adler-Milstein2
Abstract
Background: Health Information Organizations (HIOs) are third party organizations that facilitate electronic health
information exchange (HIE) between providers in a geographic area. Despite benefits from HIE, HIOs have struggled
to form and subsequently gain broad provider participation. We sought to assess whether market-level hospital and
EHR vendor dynamics are associated with presence and level of hospital participation in HIOs.
Methods: 2014 data on 4523 hospitals and their EHR vendors were aggregated to the market level. We used
multivariate OLS regression to analyze the relationship between hospital and vendor dynamics and (1) probability
of HIO presence and (2) percent of hospitals participating in an HIO.
Results: 298 of 469 markets (64%) had HIO presence, and in those markets, 47% of hospitals participated in an HIO
on average. In multivariate analysis, four characteristics were associated with HIO presence. Markets with more
hospitals, markets with more EHR vendors, and markets with an EHR vendor-led HIE approach were more likely to
have an HIO. Compared to markets with low hospital competition, markets with high hospital competition had a
25 percentage point lower probability of HIO presence. Two characteristics were associated with level of hospital
HIO participation. Markets with more hospitals as well as markets with high vendor competition (compared to low
competition) had lower participation.
Conclusion: Both hospital and EHR vendor dynamics are associated with whether a market has an HIO as well as
the level of hospital participation in HIOs.
Keywords: Health information exchange, Electronic health records, Systems integration
Background
Fragmented healthcare delivery has resulted in silos of
health information and the challenge of ensuring that
patient information is shared between providers. Infor-
mation sharing is vital to care coordination, and when
done electronically, can be more comprehensive, accur-
ate, and timely, leading to a reduction in redundant
testing, improved patient safety, and better quality of
care [1, 2]. Health Information Organizations (HIOs) are
third party organizations that provide the governance
and technical infrastructure to enable electronic health
information exchange (HIE) between providers in a geo-
graphic area. As opposed to other HIE approaches that
place restrictions on who can participate in sharing data,
such as Enterprise Health Information Exchanges or EHR
Vendor Exchanges, HIOs promote community-wide HIE
participation [3] and are a community approach to HIE
that may be less likely to lead to information blocking (the
intentional and unreasonable interference with electronic
exchange of health information) [4].
Although HIOs represent an important option for
community-level connectivity, HIOs have struggled to
identify sustainable business models, which may be driv-
ing the observed decline in the number of HIOs [5] and
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leads to uncertainty about their viability. Critical to HIO
sustainability is whether hospitals perceive participation
as valuable, which is influenced both by hospital dynam-
ics and by how EHR vendors work with HIOs. Hospitals
have expressed concern about the potential loss of
patients and revenue that could result from sharing data
with competitors through HIOs, particularly if participa-
tion costs are high. Anecdotal reports of EHR vendors
charging prohibitive fees or withdrawing support for
connectivity have raised concerns about the influence of
EHR vendors on the sustainability of HIOs, especially as
EHR vendors are increasingly offering their own HIE
networks [6].
While prior studies on HIOs have examined what pre-
dicts whether or not hospitals participate in an HIO [7],
it is not yet known whether market conditions, particu-
larly those related to dynamics of hospitals and EHR
vendors, are associated with HIO presence and the level
of hospital participation. This question has important
implications for understanding the future of HIOs and
the effectiveness of policies designed to promote their
sustainability. In particular, many HITECH policies seek-
ing to increase HIE have targeted individual organiza-
tions. To the extent that market characteristics predict
HIO presence and level of hospital participation, it may
be more effective to pursue policies at the market level.
In this study, we sought to understand how hospital
and EHR vendor market dynamics are related to HIO
presence and level of hospital participation in HIOs.
Market dynamics may hinder HIO presence if an HIO
is unable to negotiate tensions between competing hos-
pitals or vendors. Even in markets that have successfully
established an HIO, these same market dynamics may
limitthe level of hospital participation in HIOs. We
answer the following questions: (1) Do market-level hos-
pital and EHR vendor characteristics differ in markets
with and without an HIO? (2) In markets with an HIO,
are market-level characteristics associated with the level
of hospital participation in HIOs?
Methods
Data
Data on US hospitals (excluding mental, children’s, and
federal government hospitals) from the 2014 AHA
Survey and 2014 AHA IT Supplement were aggregated
to the Health Service Area (HSA) and merged with data
from the 2012 Dartmouth Atlas and the 2014 Area
Health Resource File. When 2014 AHA data was miss-
ing, we used the most recently available data from the
2008–2013 American Hospital Association (AHA)
Surveys and 2012–2013 AHA IT Supplements. Because
many HSAs contain a single hospital, areas bound by
HSAs may not adequately capture interactions between
hospitals. We therefore combined HSAs within Health
Referral Regions (HRRs, larger geographic areas created
by aggregating HSAs based on patient referrals for ter-
tiary medical care) based on whether or not there was at
least one HIO in the HSA. This effectively split HRRs
into two areas, one that contains all HSAs in the HRR
that have HIO presence, and one that contains all HSAs
in the HRR that do not have HIO presence. Each of
these areas was considered an individual market.
Markets were dropped if there were not enough hospi-
tals in the market that responded to the AHA IT Sup-
plement. If there were at least 7 hospitals in the market,
at least one-third of the hospitals in the market had to
have responded to the IT supplement to remain in the
data set. If there were fewer than 7 hospitals in the mar-
ket, at least 3 of the hospitals had to have responded to
remain in the data set. Additional markets were dropped
if no hospitals had data available for the following
revenue-related measures: percent of inpatient days from
Medicare, percent of inpatient days from Medicaid, and
percent of revenue from shared risk or capitated pay-
ment sources. A total of 72 markets were dropped (63
missing IT data and 9 missing hospital revenue-related
data) resulting in a final analytic data set of 469 markets,
representing 2648 HSAs and 4523 hospitals (Table 1).
Dependent variables
HIO presence in a market was measured using re-
sponses to a question from the AHA IT Supplement
that asked about HIOs in a hospital’s area. An HSA was
considered as having an HIO if at least one hospital in
the HSA indicated that there was an HIO in their area,
even if they did not participate. Level of hospital partici-
pation in HIOs was calculated using the percent of hos-
pitals in the market that reported actively participating
in an HIO on the AHA IT Supplement. Because HIO
participation can, by definition, only occur in markets
with an HIO, analysis of HIO participation was limited
to markets with HIO presence.
Independent variables
We selected six independent variables—three related to
hospital dynamics and three related to vendor dynam-
ics—that we hypothesized would be related to both the
likelihood of HIO presence and the level of hospital
HIO participation in markets with HIOs (Please see
Additional file 1: Conceptual Model). We chose these
variables based on those included in previous hospital-
level studies that sought to predict which hospitals en-
gage in HIE and adopt other types of health information
technologies [8, 9].
Hospital market size
A greater number of hospitals may be associated with
higher probability of HIO presence and a higher level of
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Table 1 Characteristics of markets by HIO presence and level of hospital participation
Variables All Areas No HIO Presence HIO Presence Hospital
Participation
Number of Markets 469 171 298 298
Categorical Variables n(%) n(%) n(%) P-value Mean (SD) P-value
Number of Hospitals < 0.001 < 0.001
Low (1–4) 175 (37%) 106 (62%) 69 (23%) 58% (32)
Moderate (5–8) 128 (27%) 36 (21%) 92 (31%) 41% (24)
High (9+) 166 (35%) 29 (17%) 137 (46%) 47% (25)
Total 469 171 198
Hospital Competition (HHI) < 0.001 0.33
Non-Competitive (0.46–1.00) 127 (27%) 67 (39%) 60 (20%) 59% (32)
Moderately Competitive (0.25–0.45) 166 (35%) 62 (36%) 104 (35%) 45% (26)
Highly Competitive (0.00–0.24) 176 (37%) 42 (25%) 134 (45%) 43% (20)
Total 469 171 298
For-Profit Hospital Marketshare 0.003 < 0.001
Low For-Profit Marketshare (0–57%) 357 (76%) 117 (68%) 240 (81%) 34% (34)
High For-Profit Marketshare (> 57%) 112 (24%) 54 (32%) 58 (19%) 18% (18)
Total 469 171 298
No. of EHR Vendors < 0.001 < 0.001
Low (1–2) 141 (30%) 21 (12%) 120 (40%) 55% (32)
Moderate (3–4) 146 (31%) 45 (26%) 101 (34%) 44% (25)
High (5+) 182 (39%) 105 (61%) 77 (26%) 44% (19)
Total 469 171 298
Vendor Competition (HHI) < 0.001 0.35
Non-Competitive (0.63–1.00) 144 (31%) 76 (44%) 68 (23%) 57% (31)
Moderately Competitive (0.38–0.62) 162 (35%) 57 (33%) 105 (35%) 46% (25)
Highly Competitive (0.00–0.37) 163 (35%) 38 (22%) 125 (42%) 42% (20)
Total 469 171 298
Alternative HIE Approach (%)
No (0–49% of hospitals on Epic) 256 (55%) 135 (79%) 121 (41%) < 0.001 44% (27) < 0.001
Yes (50–100% of hospitals on Epic) 213 (45%) 36 (21%) 177 (59%) 49% (24)
Total 469 171 298
Continuous Variables Mean (SD) Mean (SD) Mean (SD) P-value Coefficient (SE) P-value
Number of HSAs 6 (6) 5 (4) 6 (6) 0.018 0.16 (0.23) 0.46
% HIO Participation 30 (30) 0 (0) 47 (25) < 0.001
% Hospital Participation in Patient
Centered Medical Home and/or
Accountable Care Organizations
27 (27) 17 (26) 33 (25) < 0.001 0.003 (0.001) < 0.001
% Revenue Shared Risk Programs 1 (4) 1 (3) 2 (4) 0.062 0.12 (0.33) 0.72
% Inpatient Days Medicare 52 (21) 53 (15) 51 (9) 0.088 0.18 (0.16) 0.25
% Inpatient Days Medicaid 19 (9) 18 (10) 19 (8) 0.066 0.32 (0.19) 0.10
Hospital Beds per 1000 residents 24 (31) 15 (16) 29 (36) < 0.001 −0.09 (0.04) 0.03
FTE Hospital Staff per 1000 residents 164 (197) 98 (91) 202 (229) < 0.001 −0.01 (0.01) 0.12
Percentage of Hospitals in Urban
Settings
62 (35) 46 (39) 72 (29) < 0.001 −0.04 (0.05) 0.50
Number of Physicians (Weighted
County Average)
409 (769) 260 (737) 495 (775) 0.001 0.00 (0.00) 0.65
HIO Health Information Organization,HHI Herfindahl-Hirschman Index, EHR Electronic Health Record, HSA Health Service Area, FTE Full Time Equivalent, SD
Standard Deviation, SE Standard Error
Note: Percentages may not add up to 100% due to rounding; p-values based on ANOVA for categorical variables and linear regression for
continuous variables
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hospital HIO participation, because markets with more
hospitals have more fragmented care and therefore see a
greater need to establish an HIO and share information.
Markets were categorized as having a low, moderate, or
high number of hospitals using tertiles, which are cutoffs
that split the sample into three equal parts and resulted
in the following categories: low = 1–5 hospitals, moder-
ate = 6–10, high = 11 + .
Hospital market competition
Hospital competition may be associated with lower prob-
ability of HIO presence and lower hospital participation be-
cause hospitals that are highly competitive may prefer more
selective ways to exchange information, such as through
Enterprise HIE or direct connections [3, 8, 10, 11]. We
categorized markets as non-competitive, moderately com-
petitive, and highly competitive using the Herfindahl-
Hirschman index (HHI). The HHI is calculated using the
sum of the squared market share of each hospital in the
market. Market share was determined using the number of
hospital beds in a hospital system. After calculating the
HHI for the market, markets were categorized as non-
competitive, moderately competitive, or highly competitive
based on whether they were in top, middle, or bottom third
of the distribution for HHI, respectively (HHI of 0.447–1 =
noncompetitive, 0.239–0.439 =moderately competitive,
0–0.238 = highly competitive).
Hospital market ownership
For-profit hospitals may see HIO participation as a risky
way to exchange information, since HIO participation
makes valuable patient data more accessible and could
reduce barriers for patients to receive care at competi-
tors. Markets with a large for-profit market share may
have lower probability of HIO presence and lower
hospital participation. For-profit market share was calcu-
lated using the percent of beds owned by for-profit hos-
pitals. Markets were considered as having high for-profit
marketshare if they were in the top quartile of for-profit
marketshare (> 57%).
EHR vendor market size
A higher number of EHR vendors that are used by
hospitals in the market might increase the technical
complexity and associated costs of connecting multiple
EHR systems from different vendors [12–14]. This could
improve the attractiveness of an HIO because each hos-
pital would only need to establish a single connection to
the HIO, increasing both the probability of HIO pres-
ence and the level of hospital participation. Alternatively,
having more EHR vendors could increase the cost of
HIO formation and hospital participation, decreasing the
probability of HIO presence and reducing participation.
The number of EHR vendors was calculated by counting
the number of unique inpatient EHR vendors used by hos-
pitals in the market. Markets were categorized as having a
low, moderate, or high number of vendors using tertiles
(low = 1–2 vendors, moderate = 3–4, high = 5+).
EHR vendor market competition
In competitive vendor markets, competing EHR vendors
may be reluctant to support hospital participation in HIOs
in an effort to maintain vendor lock-in [13, 15–17]. As a
result, markets with competitive EHR vendors may have
lower probability of HIO presence and lower hospital
participation. Similar to hospital competition, vendor
competition was determined using the Herfindahl-
Hirschman Index of vendors in the market. Vendor mar-
ket share was based on the number of hospital beds in
hospitals that use the vendor’s inpatient EHR product.
Markets were categorized as non-competitive, moderately
competitive, and highly competitive based on whether
they were in the top, middle, or bottom third of the distri-
bution for vendor HHI (HHI of 0.592–1.000 = noncom-
petitive, 0.357–0.592 =moderately competitive, and 0–0.
356 = highly competitive).
Market penetration of alternative (vendor-led) HIE
approach
One specific EHR vendor - Epic - has a mature intra-
Epic HIE in which the vast majority of Epic clients
participate. Therefore, markets dominated by Epic have
an alternative to HIOs and there may be a sufficient
number of hospitals that prefer to exchange data
through Epic’s HIE platform instead of an HIO, resulting
in both a lower probability of HIO presence and lower
hospital participation. Market penetration of an alterna-
tive (vendor-led) HIE approach was measured by calcu-
lating Epic marketshare using the percent of beds owned
by hospitals whose primary inpatient vendor was Epic. A
market was considered to have an alternative HIE
approach if the Epic marketshare was greater than 50%.
We included seven market-level controls: percent of
hospitals that participate in a Patient Centered Medical
Home and/or Accountable Care Organization, average
percent of revenue from alternative payment models (e.
g. shared risk programs and capitated payments), aver-
age percent of inpatient days from Medicare/Medicaid,
number of hospital beds per 1000 residents, number of
full time hospital employees per 1000 residents, number
of physicians per 1000 residents, and percent of hospi-
tals in urban settings. These control variables were
chosen because they may confound the relationship
between hospital and EHR vendor market dynamics and
HIO presence and hospital participation in HIOs. In
markets where a higher percentage of hospital revenue
is from shared risk programs, hospitals may be more
likely to participate in an HIO effort to improve care
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coordination [12]. In markets where hospitals have a
greater percentage of inpatient days paid for by Medi-
care and Medicaid, hospitals may be more inclined to
participate in an HIO in order to meet Meaningful Use
criteria [18]. Markets with a higher density of hospital
beds, hospital staff, and physicians, as well as greater
urbanicity, may have greater need for HIE to facilitate
care coordination.
Analysis
To answer our first research question about how hos-
pital and vendor market characteristics differ for markets
with and without an HIO, we conducted bivariate ana-
lyses on market characteristics and HIO presence, and
then ran a multivariate linear probability model with
state fixed effects. A linear probability model was chosen
over the logistic model for ease of interpretation, such
that coefficients can be interpreted as a change in the
predicted probability of HIO presence given a unit
change in the independent variable. However, as a ro-
bustness test, we ran a logistic regression model and the
resulting odds ratios were compared with the linear
probability model (Additional file 2: Logistic Regression
Model for HIO Presence in Marekts with different Hos-
pital and Vendor Characteristics).
To address our second research question about how
characteristics of markets are associated with hospital
participation, we conducted bivariate analyses on
hospital participation and market characteristics using
one-way ANOVAs for categorical variables and linear re-
gression for continuous variables. We then ran a multi-
variate linear regression model with state fixed effects
using hospital participation as the dependent variable for
all markets with HIO presence.
In our dataset, the number of hospitals and number of
vendors in the market were highly correlated (correl-
ation coefficient = 0.83), while the number of hospitals
and hospital competition, the number of vendors and
vendor competition, and hospital and vendor competi-
tion were moderately correlated (correlation coefficients
= 0.50, 0.74, 0.74 respectively). High multicollinearity
may lead to two problems: (1) invalid interpretations of
model coefficients as “the expected change in an out-
come holding all other variables constant”, since, as a re-
sult of collinearity, a change in one variable necessitates
a change in the collinear variable, and (2) high standard
errors for collinear variables leading to insignificance.
We addressed multicollinearity in three ways. First, in
our primary models, we use tertiles of number of hospi-
tals and vendors, and hospital and vendor competition
instead of continuous variables. Second, as a robustness
test, we ran our models using continuous variables, to
ensure that the directionality of the estimated effect was
consistent with our primary models. Finally, we ran our
models and systematically excluded each of the collinear
variables, and then compared standard errors and statis-
tical significance to our primary models.
Results
HIO presence
In bivariate analyses, markets with and without an HIO
differed significantly for all independent variables, but
not always in the predicted direction: markets with an
HIO had more hospitals (p < 0.001), had higher hospital
competition (p < 0.001), were less likely to have high for-
profit hospital marketshare (p = 0.003), had more EHR
vendors (p < 0.001), had more competitive EHR vendors
(p < 0.001) and were more likely to have an alternative
HIE approach (i.e., be Epic dominant; p < 0.001, Table 1).
In the multivariate probability regression, most of
these variables continued to be significantly related to
HIO presence. Compared to markets with a low number
of hospitals, markets with a moderate number of hospi-
tals had a 19 percentage-point higher probability of HIO
presence (p = 0.032) and markets with a high number of
hospitals had a 19 percentage-point higher probability of
HIO presence (p = 0.006, Table 2). Compared to non-
competitive hospital markets, highly-competitive hos-
pital markets had 25 percentage-point lower probability
of HIO presence (p = 0.003, Table 2). Moderately-
competitive hospital markets had a 12 percentage-point
lower probability of HIO presence, though this effect
was not statistically significant (p = 0.058, Table 2). Mar-
kets in the top quartile of for-profit hospital marketshare
had a 7 percentage-point lower probability of HIO pres-
ence, though this effect was also not statistically signifi-
cant (p = 0.163, Table 2).
Markets with more EHR vendors were more likely to
have HIO presence. Compared to markets with a low
number of vendors, markets with a moderate number of
vendors had a 21 percentage-point higher probability of
HIO presence (p = 0.002) while markets with a high
number of vendors had a 32 percentage-point higher
probability of HIO presence (p = 0.001, Table 2). Vendor
competition did not have a statistically significant rela-
tionship with probability of HIO presence. Finally, hav-
ing an alternative HIE approach was associated with a
14 percentage-point higher probability of HIO presence
(p = 0.001, Table 2).
Hospital participation in HIO
Bivariate analyses comparing hospital participation by
market characteristics in the 298 markets with HIO
presence revealed that markets with a higher level of
HIO participation were more likely to have: (1) a low
number of hospitals (p < 0.001), (2) low for-profit hos-
pital marketshare (p < 0.001), (3) a low number of EHR
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vendors (p < 0.001), and (4) have an alternative HIE ap-
proach (p < 0.001, Table 1).
In multivariate regression analysis, two independent
variables were significantly associated with hospital par-
ticipation in HIOs. Compared to markets with a low
number of hospitals, markets with a high number of
hospitals had on average 11 percentage-points lower
hospital participation (p = 0.023, Table 2). Though not
statistically significant, markets with a moderate number
of hospitals had on average 5 percentage-points lower
hospital participation (p = 0.350, Table 2). Compared to
markets with low vendor competition, markets with high
vendor competition had on average 11 percentage-
points lower hospital participation (p = 0.043, Table 2).
Though not statistically significant, markets with moder-
ate vendor competition had 7 percentage-points lower
hospital participation (p = 0.151, Table 2).
Robustness tests
Odds ratio estimates from the logistic regression model
were similar to estimates from the linear probability
model in both relative magnitude and significance
(Additional file 2: Logistic Regression Model for HIO
PResence in Markets with Different Hospital and Vendor
Table 2 HIO Presence and Hospital Participation in Markets with different Hospital and Vendor Characteristics
Variables Linear Probability Model Coefficients for
HIO Presence
Linear Regression Coefficients for Hospital
Participation
Constant −0.232 (0.158) 54.8** (17.4)
Hospital Dynamics
Number of Hospitals (Ref: Low 1–4)
Moderate (5–8) 0.185* (0.079) −5.2 (5.8)
High (9+) 0.190** (0.068) −10.9* (4.7)
Hospital Competition (Ref: Non-competitive, HHI= 0.46–1.00)
Moderately Competitive (0.25–0.45) − 0.118 (0.063) −8.4 (4.7)
Highly Competitive (0.00–0.24) −0.252** (0.078) −10.2 (6.0)
For-Profit Hospital Market Share (Ref: Low 0–57%)
High For-Profit Hospital Market Share (> 57%) −0.067 (0.053) −5.6 (3.9)
EHR Vendor Dynamics
Number of EHR Vendors (Ref: Low 1–2)
Moderate (3–4) 0.208** (0.070) 5.4 (5.0)
High (5+) 0.318*** (0.095) 7.0 (6.6)
Vendor Competition (Ref: Non-competitive, HHI= 0.63–1.00)
Moderately Competitive (0.38–0.62) 0.033 (0.059) −6.9 (4.5)
Highly Competitive (0.00–0.37) −0.039 (0.072) −11.2* (5.6)
Alternative HIE Approach (Ref: No)
Yes (50–100% of hospitals on Epic) 0.144** (0.046) 1.2 (3.1)
Community Controls
% Hospital Participation in Patient Centered Medical
Home and/or Accountable Care Organizations
0.004*** (0.001) 0.1 (0.21)
Avg. % Revenue from Shared Risk Programs 0.004 (0.005) 0.1 (0.3)
% Inpatient Days Medicare 0.002 (0.002) 0.1 (0.2)
% Inpatient Days Medicaid 0.007 (0.004) 0.1 (0.3)
Hospital Beds per 1000 residents −0.001 (0.002) 0.1 (0.2)
FTE Hospital Staff per 1000 residents 0.000 (0.000) 0.0 (0.0)
Percentage of Hospitals in Urban Settings 0.005*** (0.001) 0.0 (0.1)
Number of Physicians (Weighted County Average) −0.000* (0.000) 0.0 (0.0)
State Fixed Effects Included Included
n 469 298
R2 0.44 0.16
Note: * p<0.05, ** p<0.01, *** p<0.001. All models include state fixed effects. Robust standard error in parentheses
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Characteristics). The result of the robustness tests for
multicollinearity showed that using continuous variables
resulted in coefficients in the same direction as in the pri-
mary models (Additional file 3: Continuous Variable
Models for HIO Presence and Level of Participation in
HIOs). Excluding collinear variables did not substantially
change standard errors (Additional file 4 and
Additional file 5: Robustness Tests for Multicolinearity).
While statistical significance did change in some cases,
these changes suggest that the collinear variables are pick-
ing up the effect of the excluded variables, resulting in ei-
ther significance if the excluded variable had an effect in
the same direction of the collinear variable, or insignifi-
cance if the excluded variable had an effect in the opposite
direction. These results suggest that the overall conclu-
sions still hold.
Discussion
This study examined the relationship between hospital
and EHR vendor market dynamics, and HIO presence
and hospital participation. We found that both hospital
and EHR vendor dynamics (number of hospitals,
hospital competition, number of vendors, and having an
alternative HIE approach) are associated with HIO
presence, while a greater number of hospitals and high
vendor competition predicts lower hospital participation.
These results supported some of our hypothesized rela-
tionships and contradicted others.
Consistent with what we predicted, markets with more
hospitals and vendors were more likely to have an HIO.
This suggests that markets with many hospitals or ven-
dors may perceive a greater need for an HIO, leading to
a greater likelihood of HIO presence. However, also as
we predicted, competitive dynamics among hospitals
appear to work against HIO presence. More competitive
hospital markets were less likely to have an HIO.
Contrary to what we predicted, vendor dynamics did not
additionally limit HIO presence. Markets with an alter-
native, EHR vendor-led approach to HIE were more
likely to have an HIO (and vendor competition was
unrelated). While this finding contradicts our hypothesis
that hospitals in markets with an alternative approach
may be less inclined to support an HIO because the
majority of hospitals can use Epic’s Care Everywhere
platform to engage in HIE, a possible explanation is that
this measure is serving as a proxy measure for health IT
market maturity, which we would expect to increase the
likelihood of having an HIO.
Our results on the level of hospital participation in
markets with HIOs similarly pointed to the influence of
hospital dynamics. Markets with more hospitals had
lower HIO participation, which was surprising given our
expectation that more hospitals would lead to greater
HIO participation. It may be that hospital perception of
HIO value is a function of the percent of hospitals in the
market participating in the HIO. That is, HIOs in larger
markets may have a harder time recruiting hospitals to
participate since it takes many more participating
hospitals to achieve the same value. Greater vendor
competition was also associated with lower HIO partici-
pation, which was consistent with our prediction and
suggests that competitive dynamics among vendors may
impact how easy they make it for hospitals to connect to
an HIO. Both findings point to the ongoing challenges
facing HIO viability.
Our study contributes to the growing literature on
HIO development and sustainability. While studies have
found that hospital participation in health information
exchange is growing [19], they do not identify how
market dynamics may be influencing the types of
exchanges that are developing. The types of health infor-
mation exchange efforts in a market have important
consequences for whether information exchange serves
to enhance patient care or strengthen strategic relation-
ships between providers [20]. Our study is consistent
with prior work that has found that hospitals in highly
competitive markets are less likely to participate in HIOs
[7, 8, 16, 19]. However, by examining EHR vendor
dynamics as well as market-level hospital dynamics as
potential inhibitors of HIO presence, we meaningfully
extend these findings by revealing that hospital com-
petition is a potential inhibitor of HIO presence in a
market, while EHR vendor competition may subse-
quently inhibit hospital participation in HIOs. An
investigation of the effect of EHR vendor dynamics
on HIOs is important to our understanding of HIO
development and sustainability as EHR vendors are
key stakeholders in HIE efforts and have the potential
to make or break efforts to achieve community-level
information exchange.
Our work has important policy implications. Through
the CMS Meaningful Use Program and HITECH fund-
ing for HIOs, policymakers have tried to create condi-
tions under which HIOs can become established and
achieve broad provider participation. Recent concerns
about their viability have primarily stemmed from
vendor dynamics – including information blocking [6]
and proprietary HIE networks [21]. In this context, we
find that both hospital dynamics and vendor dynamics
appear to be inhibiting HIO viability. It could be that
competition between hospitals inhibits the formation of
HIOs, while in areas with HIO presence, vendor compe-
tition gives rise to information blocking behaviors that
create barriers to high hospital participation.
In the interim, our results suggest that efforts to-date
have not created sufficient demand for geographically-
based HIE. Policymakers may therefore be best off
targeting market dynamics in their efforts to promote
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HIOs. For example, our results suggest that payment re-
form efforts (e.g. PCMH and ACO models) that
incentivize hospitals to take on greater risk for the cost
and quality of care that occurs in the market at large
may introduce needed incentives for hospitals to partici-
pate in HIOs. Under these models, hospital participation
in HIOs may improve the quality of care transitions,
reducing readmission rates and subsequent penalties. It
will be important to study these mechanisms directly as
well as more broadly monitor changes in HIO activity as
these policies progress and mature.
Limitations
Our study has several limitations. First, missing data
from the AHA IT supplement and AHA survey resulted
in dropping 72 markets. These markets had fewer HSAs,
lower hospital participation in PCMH and/or ACO
models, fewer hospital beds, fewer employees, fewer
physicians, fewer hospitals, were less urban, were more
likely to be non-competitive hospital markets, and have
a higher for-profit marketshare than the markets that
were not dropped (Additional file 6: Descriptive Statis-
tics for Areas in Sample and those Dropped from the
Sample), which could limit generalizability of our results.
Second, we were unable to determine whether hospitals
in a given market participated in the same or different
HIOs. Without this information, our analysis is unable
to examine the possible confounding effect of HIO com-
petition on HIO presence and HIO participation. Lastly,
the analyses are associative and should not be used to
draw conclusions about causality. Relatedly, we are un-
able to say whether our key independent variables con-
tribute to HIO formation, or whether our key
independent variables prevent HIO closures. There could
also be interactions between hospital and vendor market
dynamics that our measures failed to capture. Future re-
search should examine these as well as the impact of
ambulatory provider dynamics on HIO activity [22],
since a major function of HIE is to facilitate information
exchange with ambulatory providers.
Conclusions
Market dynamics related to hospital competition appear
to be the key factor impeding HIO presence while
vendor competition may be a key factor limiting hospital
participation in HIOs. Taken together these results sug-
gest that efforts to improve HIO sustainability may need
to address possible information blocking behaviors stem-
ming from competitive vendor dynamics and make HIO
participation more appealing to hospitals in competitive,
larger markets, which may be best facilitated by expand-
ing payment reform efforts and strengthening market-
level incentives for valuable activities that HIOs enable.
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